Genetic Profiling of Non-Small Cell Lung Cancer at RUSH with Mary Jo Fidler, MD
Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.
Nurse Honored for Breast Cancer Care
Nurse navigator Hilary Tingley, MSN, RN, CBCN: 'It's uplifting to be recognized'
Practice Sun Safety To Prevent Skin Cancer
Every day, nearly 20 Americans die of melanoma. Dermatologist Arjun Dayal, MD, encourages prevention and early detection
Brain Health & Conditions
Collaborative Brain Tumor Care in the Joan and Paul Rubschlager Building
How the new building enhances patient-centered care
Saving Lives Through Genetic Testing
Helping patients understand their risk for cancer — and ways to reduce that risk
Using Integrative Medicine To Treat the Whole Patient
Traditional medicine combines with mind-body approaches to help patients heal
Do I Really Need a Colonoscopy?
Explore an at-home colon cancer screening option
Spotlight: Erica Arteaga, Program and Administrative Support Coordinator
Building relationships is the best part of her job
Ambassadors Introduce Waterford Place to Cancer Patients
‘We’re passionate about it because we’ve been there’
Ron's Story: Back in Action After Esophageal Cancer
Surgical tech knew he wanted to be treated at RUSH, where he works